Atlas Trials

Dose Reduction and Discontinuation With Anti-Fibrotic Medications

Clinical trial NCT05779007 · COMPLETED

Trial details

NCT number
NCT05779007
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Idiopathic Pulmonary Fibrosis
Start date
2023-04-18
Primary completion
2023-07-14
Enrollment
2778

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.